Paliperidone, or 9-hydroxyrisperidone, is an antipsychotic drug sold under the trade name Invega, an extended-release formulation. An “atypical”, or second-generation, antipsychotic, it is an active metabolite of the older drug risperidone. It was approved by the FDA in 2006 for treating schizophrenia and bipolar mania. An improved synthesis of paliperidone is described in the May 2, 2011 edition of Patent Watch.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.